B7C-16550-11690
2 vaccinations
1 coded response
18 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 405 / KY
- Registered
- 2022-10-20
- Relationship
- Child or adolescent in my care
- Guardian
- TSP-47608-26675
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-10-19
Dose 1 — ModernaCo-administered: Hib:Polio:Rotavirus:Tetanus
-
2022-10-20
Registered in v-safe
- 2022-10-21
- 2022-10-22
- 2022-10-23
- 2022-10-24
- 2022-10-25
- 2022-10-28
- 2022-11-04
-
2022-11-11
Survey response — day 21, dose 1, under 3MedDRA: Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend schoolFree text: RSVMedDRA releases: 2024-11 · check-in free text available
- 2022-11-16
-
2022-11-18
Dose 2 — Moderna
- 2022-11-23
- 2022-11-25
- 2022-12-02
- 2022-12-09
- 2022-12-16
- 2022-12-23
- 2022-12-30
- 2023-02-17
- 2023-05-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-10-19 | Moderna | Hib:Polio:Rotavirus:Tetanus |
| 2 | 2022-11-18 | Moderna | No |
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: RSV
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Respiratory syncytial virus infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release